Media-OutReach Newswire Potential Impact of Takeda's Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results
Media-OutReach Newswire Fluxergy, Inc. Receives CE-IVD Marking for a One-Hour COVID-19 RT-PCR Test and Positions for European Market Entry
Media-OutReach Newswire AIA Singapore pays tribute to essential workers, providing them with free protection, AIA #ShareTheLove Insurance plan, against infectious diseases including COVID-19 and dengue fever
Media-OutReach Newswire Lawrence Ho's Family Office Black Spade Capital Makes its First Move in the Medical IT Space via My Platform
Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial